ADAGIO Analysis Demonstrates That The Natural Progression Of Clinical Symptoms In Parkinson's Disease May Be Slower In Earlier Stages
Links shared publicly online about this topic.
- 1,224total visits
ADAGIO Analysis Demonstrates That The Natural Progression Of Clinical Symptoms In Parkinson's Disease May Be Slower In Earlier Stages
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced results from the placebo group analyses of the ADAGIO study (Attenuation of Disease progression with AZILECT® GIven Once-dail
View full resource at medicalnewstoday.com
Tags: Parkinson's Disease, Disease and Condition, Pharma, Teva Pharmaceutical Industries
Most Recently Shared on April 21, 2010 at 12:16 pm By:
ADAGIO Analysis Demonstrates That The Natural Progression Of Clinical Symptoms In Parkinson's Disease May Be Slower In... http://mnt.to/3Bwt
Advertisement
